US Patent 7304061 Heterocyclic inhibitors of ERK2 and uses thereof
Patent 7304061 was granted and assigned to Vertex Pharmaceuticals on December, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Alexander Aronov0
Francois Maltais0
Judith Straub0
Michael Robin Hale0
Qing Tang0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+110 characters)
Article
Patent abstract
Described herein are compounds that are useful as protein kinase inhibitors having the formula:
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07304061 Heterocyclic inhibitors of ERK2 and uses thereof US Patent 7304061 Heterocyclic inhibitors of ERK2 and uses thereof
Infobox
Patent Number
073040610
Patent Number
73040610
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073040610
Date of Patent
December 4, 2007
0Patent Application Number
104242800
Date Filed
April 25, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07304061 Heterocyclic inhibitors of ERK2 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07304061
Date of patent
December 4, 2007
Patent application number
10424280
Date Filed
April 25, 2003
Patent primary examiner
Find more entities like US Patent 7304061 Heterocyclic inhibitors of ERK2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
